Evidence map›Paper›PMID 34945611›Full record

ArticleFoods (Basel, Switzerland)2021

Exopolysaccharide Produced by

Fenglian Ma, Yinglong Song, Mengying Sun, Arong Wang, Shujuan Jiang, Guangqing Mu, Yanfeng Tuo

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. ProbioticJournal of microbiology and biotechnology · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. From gut to kidney: microbiota modulates stone risk through inflammation-a mediated Mendelian randomization study.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Antioxidant Role of Probiotics in Inflammation-Induced Colorectal Cancer.International journal of molecular sciences · 2024
    Review
  14. Review
  15. Review
  16. Appraisal of postbiotics in cancer therapy.Frontiers in pharmacology · 2024
    Review
  17. Article
  18. Frontiers in microbiology · 2024
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fenglian MaSchool of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, China.
Yinglong SongSchool of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, China.
Mengying SunSchool of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, China.
Arong WangSchool of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, China.
Shujuan JiangSchool of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, China.
Guangqing MuSchool of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, China.
Yanfeng TuoSchool of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, China.ORCID 0000-0001-7255-3753
Dalian Polytechnic University · CN

Funding

National Natural Science Foundation of China 31571813, 32072194
6 · The paper itself

Abstract

Exopolysaccharide produced by

Indexed as

colon cancerexopolysaccharidegut microbiotaLactiplantibacillus plantarummetabolite

Identifiers

PMID34945611
PMCPMC8701795
OpenAlexW4200101677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.